A veterinary trial found fewer further cluster seizures with an adjunct regimen, while both groups received a shared treatment pathway.
Fifty-seven dogs were enrolled in an open-label study. Background care included intravenous or rectal diazepam and intravenous phenobarbital. One group also received rectal levetiracetam. Because few dogs had status epilepticus, statistical response analysis focused on cluster seizures.
The reported response difference cannot isolate levetiracetam versus diazepam as single agents. Open-label assignment, unequal groups and selected clinical cases also constrain certainty. The authors called for a blinded placebo-controlled trial. These findings apply to dogs, not human home seizure rescue. The paper illustrates why a drug mentioned in the control regimen should not be mistaken for the sole comparator, and why cluster-seizure results cannot automatically be expanded to status epilepticus.
Original analysis of the supplied journal article, identified as PMC6639497.